Revvity Inc
revvity.comRevvity Inc (NYSE: RVTY) is a life sciences and diagnostics company that develops and sells products, services, and solutions serving scientific research and clinical diagnostics markets. Revenue is generated across two reported segments, Life Sciences and Diagnostics, through a combination of instrument sales, reagent and consumable sales, and service offerings. The company grows through internal research and development investment as well as strategic acquisitions and licensing of technology. Revvity's fiscal year ended December 28, 2025, as reported in its 10-K filed February 24, 2026. The company's stated strategy includes expanding its global product and service offerings across both segments, pursuing mergers and acquisitions, and advancing artificial intelligence applications within its product portfolio and internal operations. Capital allocation priorities include organic investment, acquisitions, and opportunistic share repurchases.
Products & Services
Products and services across Life Sciences and Diagnostics segments, including instruments, reagents, consumables, and associated services. Specific product names are not detailed in the available filing excerpts.
Revenue Model
Transactional and recurring revenue from instrument sales, consumables, reagents, and services across two segments: Life Sciences and Diagnostics. Growth is augmented through acquisitions and licensing (per 10-K, filed 2026-02-24).
Customers & Markets
Customers in scientific research and clinical diagnostics. End markets include life sciences research and diagnostics, with a focus on high-growth markets as stated in the FY2025 10-K.
Geographic Exposure
Global operations with international product and service offerings; specific geographic revenue breakdown not supported by the available filing excerpts.
Loading...
